Steven Cohen Dyne Therapeutics, Inc. Transaction History

Point72 Asset Management, L.P.

$40.1 Billion
Q1 2025

A detailed history of Steven Cohen (Point72 Asset Management, L.P.) transactions in Dyne Therapeutics, Inc. stock. As of the latest transaction made, Point72 Asset Management, L.P. holds 1,528,534 shares of DYN stock, worth $18 Million. This represents 0.04% of its overall portfolio holdings.

Number of Shares

1,528,534

Previous 924,681 65.3%

Holding current value

$18 Million

Previous $21.8 Million 26.61%

% of portfolio

0.04%

Previous 0.05%

19 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2025 May 15, 2025	BUY	$10.46 - $25.46 $6.32 Million - $15.4 Million	603,853 Added 65.3%	1,528,534 $16 Million
Q4 2024 Feb 14, 2025	BUY	$23.56 - $35.55 $19.4 Million - $29.2 Million	822,201 Added 802.3%	924,681 $21.8 Million
Q3 2024 Nov 14, 2024	SELL	$31.94 - $47.04 $8.15 Million - $12 Million	-255,038 Reduced 71.34%	102,480 $3.68 Million
Q2 2024 Aug 14, 2024	SELL	$23.65 - $35.63 $7.78 Million - $11.7 Million	-328,916 Reduced 47.92%	357,518 $12.6 Million
Q1 2024 May 15, 2024	BUY	$13.06 - $29.18 $3.88 Million - $8.67 Million	297,234 Added 76.37%	686,434 $19.5 Million
Q4 2023 Feb 14, 2024	SELL	$6.62 - $13.64 $1.24 Million - $2.55 Million	-186,600 Reduced 32.41%	389,200 $5.18 Million
Q3 2023 Nov 14, 2023	BUY	$8.6 - $12.18 $1.27 Million - $1.79 Million	147,271 Added 34.37%	575,800 $5.16 Million
Q2 2023 Aug 14, 2023	SELL	$8.53 - $14.28 $4.2 Million - $7.03 Million	-492,606 Reduced 53.48%	428,529 $4.82 Million
Q1 2023 May 15, 2023	SELL	$10.88 - $15.0 $5.08 Million - $7 Million	-466,533 Reduced 33.62%	921,135 $10.6 Million
Q4 2022 Feb 14, 2023	SELL	$9.37 - $13.8 $1.03 Million - $1.52 Million	-109,963 Reduced 7.34%	1,387,668 $16.1 Million
Q3 2022 Nov 14, 2022	BUY	$7.2 - $15.17 $944,863 - $1.99 Million	131,231 Added 9.6%	1,497,631 $19 Million
Q2 2022 Aug 15, 2022	SELL	$4.36 - $10.5 $2.27 Million - $5.48 Million	-521,500 Reduced 27.62%	1,366,400 $9.39 Million
Q1 2022 May 16, 2022	BUY	$6.52 - $12.27 $4.13 Million - $7.77 Million	633,100 Added 50.45%	1,887,900 $18.2 Million
Q4 2021 Feb 14, 2022	BUY	$11.89 - $16.07 $5.09 Million - $6.87 Million	427,800 Added 51.73%	1,254,800 $14.9 Million
Q3 2021 Nov 15, 2021	BUY	$15.6 - $21.46 $2.28 Million - $3.14 Million	146,100 Added 21.46%	827,000 $13.4 Million
Q2 2021 Aug 16, 2021	BUY	$15.94 - $22.33 $5.22 Million - $7.32 Million	327,785 Added 92.83%	680,900 $14.3 Million
Q1 2021 May 17, 2021	BUY	$14.0 - $29.3 $4.94 Million - $10.3 Million	353,115 New	353,115 $5.48 Million
Q4 2020 Feb 16, 2021	SELL	$16.81 - $23.94 $336,200 - $478,800	-20,000 Closed	0 $0
Q3 2020 Nov 16, 2020	BUY	$20.0 - $23.9 $400,000 - $478,000	20,000 New	20,000 $404,000

Others Institutions Holding DYN

# of Institutions

216

Shares Held

116M

Call Options Held

322K

Put Options Held

66.2K

View Full List

About Dyne Therapeutics, Inc.

Ticker DYN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 51,765,400
Market Cap $609M
Description
Dyne Therapeutics, Inc., a muscle disease company, operates as a biotechnology company that focuses on advancing therapeutics for genetically driven muscle diseases in the United States. It develops various programs for myotonic dystrophy type 1, duchenne muscular dystrophy, and facioscapulohumeral dystrophy, as well as rare skeletal muscle, and...

More about DYN

Track Steven Cohen's Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Point72 Asset Management, L.P., based on Form 13F filings with the SEC.

News

Stay updated on Point72 Asset Management, L.P. and Steven Cohen with notifications on news.

Account